Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Trends: Insider at Abbott Laboratories Makes Tax Sale Extends 90-Day Selling Trend

06/07/2021 | 05:35pm EDT


© MT Newswires 2021
All news about ABBOTT LABORATORIES
11:43aABBOTT LABORATORIES : - half of americans living with diabetes may be consuming ..
AQ
07/29NEW STUDY : Half of Americans Living with Diabetes May be Consuming Less Than th..
PR
07/27Global markets live: LVMH, Michelin, Tesla, Amazon, Activision...
07/23ABBOTT LABORATORIES : Jefferies & Co Adjusts Abbott Laboratories PT to $135 From..
MT
07/23ABBOTT LABORATORIES : JPMorgan Adjusts Abbott Laboratories PT to $135 From $122,..
MT
07/23ABBOTT LABORATORIES : Morgan Stanley Adjusts Abbott Laboratories PT to $136 From..
MT
07/23ABBOTT LABORATORIES : Raymond James Adjusts Price Target on Abbott Laboratories ..
MT
07/23ABBOTT LABORATORIES : Credit Suisse Raises Abbott Laboratories' PT to $130 from ..
MT
07/23ABBOTT LABORATORIES : UBS Adjusts Abbott Laboratories' PT to $131 From $127, Cit..
MT
07/23ANALYST RECOMMENDATIONS : Apple, Aviva, Biogen, Comerica Incorporated, Tesla...
More news
Financials (USD)
Sales 2021 39 766 M - -
Net income 2021 5 967 M - -
Net Debt 2021 8 719 M - -
P/E ratio 2021 36,1x
Yield 2021 1,41%
Capitalization 215 B 215 B -
EV / Sales 2021 5,63x
EV / Sales 2022 5,59x
Nbr of Employees 109 000
Free-Float 89,0%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | MarketScreener
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 121,09 $
Average target price 128,81 $
Spread / Average Target 6,38%
EPS Revisions
Managers and Directors
Robert B. Ford President, CEO, Chief Operating Officer & Director
Robert Emmett Funck Chief Financial Officer & Executive Vice President
Miles D. White Executive Chairman
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Roxanne Schuh Austin Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABBOTT LABORATORIES10.07%215 155
MEDTRONIC PLC11.42%175 621
BECTON, DICKINSON AND COMPANY2.03%74 249
ALIGN TECHNOLOGY, INC.26.69%53 574
HOYA CORPORATION7.95%52 325
SARTORIUS STEDIM BIOTECH62.09%51 723